Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 15Rectal Neoplasms 4Pancreatic Neoplasms 3Colonic Neoplasms 3Esophageal Squamous Cell Carcinoma 2Cholangiocarcinoma 2Biliary Tract Neoplasms 2Stomach Neoplasms 1Rhabdomyosarcoma 1Rare Tumour 1Pathologic Complete Response 1Pancreatic Cancer Resectable 1Neoplasms, Second Primary 1Neoplasm, Residual 1Neoplasm Metastasis 1Medulloblastoma 1Lung Neoplasms 1Locally Advanced Low Rectal Adenocarcinoma 1Esophageal Neoplasms 1Cirrhosis, Familial, with Pulmonary Hypertension 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Neuroendocrine 1CRC 1Biliary Cancer Metastatic 1Appendiceal Neoplasms 1Advanced Malignant Neoplasm 1Advanced Esophageal Carcinoma 1

Interventions

Gemcitabine 2sintilimab 1Taxes 1Oxaliplatin 1Leucovorin 1Irinotecan 1Fluorouracil 1Capecitabine 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Pancreatic Cancer Resectable × Irinotecan × Clear all
NCT07155629 2025-09-04

LEFT-PANC

Helsinki University Central Hospital

Phase 3 Not yet recruiting
381 enrolled
Gastrointestinal

Pancreatic Cancer Resectable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡